Stock Shastra

The current state of high volatility in the stock markets is by now apparent to all investors. In these market conditions, the chances of making wrong investment decisions and losing your money are very high, too.

In such a situation, investing in blue-chip stocks is the solution to our problems! Though they have a reputation of being boring and outdated, they can prove to be quite a saviour.

So, what are blue chip stocks? And is it a good time to start investing in blue chip stocks?

The Union Budget 2012-13 was a pretty disappointing one for the common man with no major reforms announced. Even on the tax front, there was just a marginal increase in the tax slabs and reduction in STT. The only interesting thing for a retail investor was the introduction of a new scheme called the Rajiv Gandhi Equity Saving Scheme (RGESS).
So, what does this scheme entail and what does it mean for you?

With the Union Budget 2012-2013 around the corner, the common man and the industry alike, await its arrival. The Indian economy has seen a lot of turbulence in the year gone by, in the face of global macro-economic crisis, high inflation and interest rates, rupee devaluation, policy bottlenecks, etc.

But all this has soared expectations to a very high level.

Let’s take a sneak-peek.

Many of you may be aware that we are initiating a new series of Company Shastra, which will cover safe stocks having favorable future growth opportunities. Our first pick for this series is Biocon- the leader in the biotech sector.

Biocon is an integrated healthcare company manufacturing biopharmaceuticals and providing research services. A highly innovative company, it has strong R&D capabilities which have resulted in creating potential blockbuster products in its research pipeline. While its contract research services are picking up pace, it is also well placed to benefit from the Biosimilar opportunity in key regulated markets with products going off-patent in 2014-2018E. However, higher R&D costs (as the product pipeline advances) are expected to act as a margin dampener for the next few years. Considering this, should you invest in Biocon Ltd.?

However, higher R&D costs (as the product pipeline advances) are expected to act as a margin dampener for the next few years. Considering this, should you invest in Biocon Ltd.?

Kingfisher down 5% after Mumbai airport scraps credit line….. Infosys recoups losses; stock back above 2700 mark…We are all very used to reading such headlines; where any negative news dampens your spirits, a positive one leaves you elated. These fluctuations are part of the daily stock market workings. But have you ever wondered why stock prices fluctuate?
In this simple article, Liane talks about the some of the basic reasons for fluctuation in the stock prices and the various strategies adopted by investors to gain from these.